Abstract
Not only is it crucial to develop more efficient and new anticancer drugs, but it is also essential to develop ways to precisely deliver drugs to cancer cells and understand this process's fundamentals. The aberrant overexpression of specific glycosphingolipids tightly associates with the initiation of a tumor and its malignant transformation. Therefore, the carbohydrate-binding